UT Psychiatry, a leader in mental health research and care in Memphis, is proud to be among the first in the region to offer Transcranial Magnetic Stimulation (TMS) for patients with treatment-resistant Major Depressive Disorder. This specialized treatment is available through referral, enabling healthcare providers to offer their patients a cutting-edge option when traditional treatments have not provided relief for their patients.
Transcranial Magnetic Stimulation (TMS) is an FDA-approved technique that employs a
magnetic field generator, or “coil” positioned near the forehead to specifically target the
prefrontal cortex. Each session lasts approximately 45 minutes, with the typical treatment plan involving 36 sessions over six weeks. The non-invasive nature of TMS allows patients to remain awake and alert during treatment, minimizing disruption to their daily lives and avoiding the side effects associated with anesthesia.
“As one of the very few institutions in the Memphis area to provide TMS therapy, UT Psychiatry is uniquely positioned to serve those suffering from major depression who have not found relief with traditional treatments,” said Brandon Williams, Vice President of Quality Programs and Primary Care at University Clinical Health.
“Our commitment to incorporating advanced treatments like TMS reinforces our dedication to enhancing patient care and uniquely positions us to partner with other physicians in the area seeking advanced treatment for their patients.”
TMS therapy is designed to be non-invasive and non-systemic, with side effects typically limited to mild headaches or scalp irritation. UT Psychiatry utilizes the advanced MagVenture system with a figure of 8 coil, which is specifically approved for the treatment of Major Depressive Disorder. Ongoing research into TMS at UT Psychiatry seeks to broaden understanding and enhance the efficiency of this therapy.
UT Psychiatry is committed to a compassionate, patient-centered approach, embracing diversity and inclusion in all its practices. The department encourages healthcare providers to consider TMS therapy for their patients with treatment-resistant depression as part of a comprehensive approach to mental health care.
